NYSE American · CVM
Prices delayed by 15 minutes · 12 November 2026
The series is stated in the current share scale after splits; dividends are not included in the price
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Cel-Sci Corporation (CVM) is a company in the Health care sector; its shares trade on NYSE American.
The price of Cel-Sci Corporation (CVM) on November 12, 2026 is 1.21 $, −7.63 % on the day. Over 52 weeks the stock traded between 0.8900 $ and 7.80 $; the price now sits 5 % of the way up that range. Over the past year the price changed by −81.50 %. Market capitalization is 5.29 million $, rank 124 among 134 stocks of the same industry with a known capitalization.
Cel-Sci Corporation trades on NYSE American under the ticker CVM. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CVM has traded between 0.8900 $ and 7.80 $. As of 12 November 2026 the price stood 6.08% of the way from the 52-week low to the high.
Over one year CVM shares fell 81.50%; over six months they rose 9.17%. Volatility over 90 days is 97.50%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.5, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
Cel-Sci Corporation reported revenue of −444,019 $ and a net loss of 23M $ over the last four quarters. Earnings per share are −$1.69. Market capitalisation is 5M $.
CVM has a return on equity of −207.23%, below the sector median of −40.58%. Return on assets is −106.31%, below the sector median of −30.08%.